KIMS Hospital Bengaluru commences operations at PES University campus
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The inspection concluded with one minor observation in Form 483
The FDA aims to make a decision by April 8, 2026
Golcadomide, a CELMoD agent, continued to deliver deep and durable responses in aggressive B-cell and follicular lymphomas
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Akero became a wholly owned subsidiary of Novo Nordisk
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
Columvi combined with gemcitabine and oxaliplatin dramatically extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
Subscribe To Our Newsletter & Stay Updated